XSD State Street SPDR S&P Semiconductor ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| MRVL | 3.24% |
| POWI | 3.07% |
| CRUS | 2.98% |
| LSCC | 2.88% |
| ON | 2.88% |
| MPWR | 2.86% |
| PI | 2.83% |
| SLAB | 2.83% |
| MTSI | 2.82% |
| AMD | 2.81% |
ETF Analysis
Fund Overview
State Street SPDR S&P Semiconductor ETF (XSD) currently reports 44 stock positions (subject to change), placing it in the diversified without being diffuse range by holdings breadth. The top line-up is MRVL (3.24%), POWI (3.07%), CRUS (2.98%), with MRVL as the largest single weight at 3.24%. Together, the top three holdings account for 9.29%, which suggests a more balanced distribution of weight across the portfolio, reducing single-name sensitivity at the top. Taken together, the portfolio's structure reflects a deliberate trade-off between conviction at the top and risk spreading across the broader holding set.
Profitability & Capital Efficiency
On a capital return basis, ROIC is 10.55%, WACC is 12.99%, and the economic spread is -2.44%. On balance, returns on capital are currently insufficient to clear the funding cost hurdle, which historically correlates with pressure on long-term value creation. Supporting metrics show ROE at 7.64% and ROA at 4.76%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that likely needs operating improvement before returns quality can be considered durable.
Valuation
On an earnings multiple basis, trailing P/E of 24.82, forward P/E of 21.58, PEG of 1.39. The gap between trailing and forward multiples is not especially wide, suggesting the market is pricing a steadier earnings path rather than a sharp near-term re-rating. At this PEG level, growth-adjusted valuation looks attractive — the market appears to be paying a reasonable price for the earnings growth embedded in estimates. A current ratio of 5.09 across the holding set reflects strong short-term liquidity. Combining multiples and liquidity, the portfolio appears adequately priced for its current earnings trajectory, with balance sheet health providing a degree of downside resilience.
Margins & Cash Generation
Stripping to unit economics, gross margin sits at 51.66%, operating margin at 8.11%, and free cash flow margin at 21.67%. Gross margins are healthy, suggesting solid pricing power across the underlying holdings. At this operating margin level, cost efficiency is present but limited — overhead is a visible drag on earnings conversion. At this FCF margin level, the underlying holdings demonstrate good cash generation relative to the revenue base. Across the three margin layers, the picture is inconsistent — a reminder that aggregate metrics can mask meaningful variation at the individual holding level.
Growth & Forward Outlook
Connecting operational trends with market expectations, TTM revenue growth of 26.90% indicating strong organic momentum at the portfolio level, while the estimated 12-month price change of 25.65%, where consensus targets suggest reasonable upside rather than a step-change rerating. At 15.0%, the projected 12-month EPS growth rate is strong enough to be a primary driver of the forward investment case rather than a peripheral supporting detail. Operating momentum and analyst expectations are related but distinct — the former is backward-looking by nature, the latter inherently speculative. Against that backdrop, the more durable question is whether operating trends can be sustained long enough for analyst expectations to be validated. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
BuyOverall, the fundamentals support a constructive stance — execution remains the key driver of whether the forward case is fully validated.
The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.